Samples from patients with SCAs (n = 15) and with invasive IPMNs (n = 11) were thus also screened for 9 previously established high-grade IPMN biomarkers MUC5AC, Das-1, MUC1, STMN1, TSP2, EGFR, WNT-2, EpCAM, and EphA213. This evidence concerns the gene EPCAM and pancreatic intraductal papillary-mucinous neoplasm.